
The authors present practical aspects of cochlear implantation, resulting from over 25 years of a deafness treatment program at the Department of Otorhinolaryngology, Head Neck Surgery of the Medical University of Warsaw. The classic surgical technique for typical anatomical conditions is now well-codified, and insertion of the implant's active electrode should be performed through the facial nerve recess. A wide posterior tympanotomy facilitates electrode insertion maneuvers, especially in difficult intraoperative conditions. A key element of the operation is proper opening of the inner ear and complete, atraumatic insertion of the electrode into the scala tympani. In clinically challenging situations (coexisting middle ear inflammation, anatomical defects, or inner ear obliteration), lateral petrosectomy is indicated. Expanded surgical indications include implantation during the removal of VIII th nerve tumors and labyrinthectomy for Menier's disease. In both of these clinical situations, implant electrode insertion is also performed through the facial nerve recess. The surgical procedure for cochlear implantation is based on classical techniques known in otology. Any otosurgeon specializing in middle ear surgery and capable of properly performing a posterior tympanotomy is qualified to perform cochlear implantation.
Introduction: Warthin’s tumor (WT), also known as papillary cystadenoma lymphomatosum, is the second most common salivary gland tumor, accounting for approximately 15% of all salivary gland tumors (SGTs) and 24% of benign tumors. Rarely, WT may develop in extraparotid locations of the head and neck, including the minor salivary glands. Because of its histologic features, the diagnosis of Warthin’s tumor can sometimes be challenging, especially in extraparotid locations. We present a case of WT mimicking squamous cell carcinoma (SCC), with a second WT focus in the palatine tonsil, an unprecedented location. To our knowledge, this is the first such case described in the available literature. Aim: To present a case initially suspected to represent cervical carcinoma of unknown primary (cCUP), which was ultimately diagnosed as Warthin’s tumor of the parotid gland with a second focus in the palatine tonsil. Case report: A 73-year-old woman presented with a mass in the region of the left mandibular angle. Fine-needle aspiration biopsy suggested a lesion suspicious for malignancy, classified as category V according to the Milan classification. MRI of the head and neck revealed a complex mass with solid and cystic components located at the border of the inferior pole of the parotid gland and the posterior pole of the submandibular gland. The patient was scheduled for excision of the neck mass with lymph node dissection, as well as panendoscopy and bilateral tonsillectomy. Intraoperatively, a lesion of the inferior pole of the parotid gland was identified; therefore, the procedure was extended to include superficial parotidectomy with preservation of the facial nerve. Deep cervical lymph nodes of levels II and III on the left side were removed. Bilateral tonsillectomy was performed. No mucosal lesions of the upper aerodigestive tract were visualized on panendoscopy. Blind biopsies were taken from the nasopharynx and the base of the tongue. Final histopathological examination revealed a Warthin’s tumor in the left parotid gland and a 4-mm WT focus in the left palatine tonsil. Conclusions: Warthin’s tumors can mimic metastases of squamous cell carcinoma, exposing patients to high-risk procedures. Awareness of the possibility of papillary cystadenoma lymphomatosum occurring in various locations within the head and neck structures, including extra-salivary sites, may help pathologists and clinicians consider this diagnosis in the differential diagnosis of suspicious oncologic lesions.
Introduction: Drug-induced sleep endoscopy (DISE) of the upper airway is an important component of the diagnostic work-up of patients with obstructive sleep apnea (OSA), particularly in those being considered for surgical treatment. DISE enables dynamic assessment of the site and mechanism of upper airway collapse during pharmacologically induced sleep and facilitates individualized treatment planning. Aim: The aim of this paper is to present a practical protocol for performing DISE (“How I Do It”), including pre-procedural assessment and preparation, sedation, endoscopic assessment, and interpretation of the observed patterns of upper airway collapse. Method: A step-by-step description of our approach to DISE is provided, with particular emphasis on patient selection, monitoring of vital parameters, sedation management, and examination technique. The assessment of individual anatomical levels of the upper airway according to the VOTE classification is described, together with the role of additional diagnostic maneuvers, including the Esmarch maneuver and the use of an oral appliance. The most common patterns of upper airway obstruction and their implications for treatment planning are also discussed. Conclusions: DISE requires a standardized protocol and adequate experience of the team performing the procedure. When properly performed and evaluated, DISE provides important information about the mechanisms of upper airway obstruction and supports treatment decision-making in patients with OSA, particularly those being considered for surgical treatment.
Introduction: Benign paroxysmal positional vertigo is the most common cause of vertigo worldwide; a subclinical or subjective variant of the disease is defined as the presence of subjective vertigo without corresponding nystagmus; it accounts for 11.5% of all cases of benign paroxysmal positional vertigo. Aim: To identify the usefulness of the Alsarhan (Rapid Bilateral Sitting Up) maneuver in the treatment of subjective benign paroxysmal positional vertigo. Materials and methods: This was a prospective preliminary study of 32 patients who presented with subjective benign paroxysmal positional vertigo, underwent the Alsarhan maneuver, and were followed up for a period of one month for any recurrence of the disease. Results: The Alsarhan maneuver was useful in 84.4% of cases; the usefulness rate was statistically significant. Conclusions: The Alsarhan maneuver can be a promising method for treating this condition.
Introduction: The EULAR has accepted the OMERACT Salivary Gland Ultrasound (SGUS) scoring system for major salivary glands as a useful tool for investigating Sjögren’s disease (SJD) and staging the severity of salivary gland disease. SGUS is suggested as an additional tool for investigation. Aim: To determine the sensitivity and specificity of investigations, the role of SGUS and to evaluate the severity of Sjögren’s disease according to OMERACT gray- scale guidelines. To correlate SGUS findings with clinical disease grade and serological markers used in diagnostic criteria. Materials and methods: Study design: Prospective study involving patients with sicca symptoms and symptoms of salivary gland involvement; Study participants: 15 patients were included (planned 30). The diagnosis of Sjögren’s disease was made according to the ACR criteria with the use of SGUS along with Minor salivary gland Biopsy (MSGB) performed after receiving consent. Patients with DED and dry mouth symptoms were evaluated using ESSDAI scoring and screened with Schirmer’s test, corneal staining, routine blood counts, ESR, and SGUS. SGUS is performed using a high-frequency probe. Inclusion Criteria: Patients with definite sicca symptoms were included and subjected to serological investigations. Both SJD and autoimmune disorders with sicca symptoms are included in the study. Results: Parotid glands were predominantly affected, and ANA was detected in 92.9% of patients. Anti-SS-A and Anti-Ro52 antibodies were present in 71.4%. SGUS findings were present in all SJD cases. The grade of SGUS correlated with the levels of antinuclear antibody levels (grade 2 and grade 3 changes). Patients with idiopathic sicca syndrome had the lowest SGUS grades. Conclusions: Sicca symptoms are common, but Schirmer’s test results do not correlate with the systemic manifestations of the disease. SGUS grade correlates with disease severity in SJD. SGUS changes were found in patients with normal anti-SSA antibody results and otherwise negative diagnostic criteria.